Participants 79 94 3
type 2 diabetes
Participants 293 322 4
patients with type 2 diabetes
Participants 454 478 4
type 2 diabetic patients
Participants 617 709 7
eight patients with type 2 diabetes who were being treated with oral glucose-lowering agents
